Zinc forms compared: picolinate vs gluconate vs bisglycinate vs carnosine

Updated 2026-05-20 · Reviewed by SupplementScore editors · No sponsorships · No affiliate links

The four forms of zinc you'll see most often on shelves serve genuinely different jobs. Picolinate dominates daily-repletion marketing on the strength of one small 1987 study; gluconate is the form used in almost every cold-duration trial; bisglycinate is the one most people switch to when other forms upset their stomach; and zinc-carnosine (polaprezinc) is a prescription-grade Japanese gastric drug being sold as a supplement in the rest of the world. Their head-to-head evidence is uneven — which is exactly the point of this comparison.

TL;DR — which zinc form for which goal

Why "elemental zinc" is the only number that matters

A zinc supplement is a zinc cation bound to a counter-ion (picolinic acid, gluconic acid, glycine, carnosine, oxide, sulfate, etc.). The label number you care about is the elemental zinc per dose — not the weight of the whole compound. A 50 mg zinc gluconate capsule delivers roughly 7 mg elemental zinc; a 50 mg zinc picolinate capsule delivers about 10 mg; a 200 mg zinc-carnosine capsule delivers about 33 mg elemental zinc. The recommended dietary allowance is 8–11 mg/day, the upper limit for adults is 40 mg/day from supplements (40 mg, not 40 mg of compound), and most positive RCTs use 15–50 mg elemental zinc/day in non-cold-lozenge studies [1].

Marketing routinely conflates compound weight with elemental dose. If you see a "100 mg zinc" capsule without an elemental-content callout, assume the elemental dose is one-fifth to one-third of that number. Long-term intake above 40 mg/day elemental zinc carries a real risk of copper deficiency through reciprocal absorption interference — a concern relevant to all four forms in this comparison [1].

Zinc picolinate

Zinc picolinate is zinc bound to two picolinic acid molecules (a metabolite of tryptophan). The form's reputation as "best-absorbed" traces back almost entirely to a single 1987 study in 15 healthy adults that found higher RBC, hair, and urinary zinc after four weeks of picolinate vs citrate vs gluconate vs placebo [2]. That study has been repeatedly cited in marketing copy for nearly four decades; it has never been convincingly replicated. Independent reviews put picolinate's absorption within the broad envelope of other organic chelates, not at the top of it.

What it's reasonable to say: picolinate is well-absorbed, well-tolerated at standard 15–30 mg elemental doses, and indistinguishable from bisglycinate or gluconate in clinical-endpoint trials for which any of them was the active arm. It is meaningfully better-absorbed than zinc oxide (the inorganic salt found in cheap multivitamins) — though so are all the other organic forms in this comparison.

Where picolinate has no special edge: cold-duration trials (those use lozenges, not capsules; the active mechanism is local), gastric-mucosa endpoints (no carnosine moiety), or any context where bisglycinate would be a slightly more tolerable swap. The form's price-per-elemental-zinc is roughly 1.5–2× zinc gluconate.

Cost-per-dose: $0.05–0.15 per 15–30 mg elemental serving. Reasonable, but not cheaper than gluconate for the same repletion job.

Zinc gluconate

Zinc gluconate is zinc bound to two molecules of gluconic acid. It's the form used in the bulk of cold-duration trial literature. The seminal 1996 Mossad RCT at the Cleveland Clinic used 13.3 mg elemental zinc lozenges every two waking hours and reported a roughly 3-day reduction in median cold duration vs placebo [3]. The result has been partially replicated and partially failed-to-replicate over the intervening 30 years. The 2013 Cochrane review (since withdrawn for re-analysis and recently updated) concluded that ionic zinc lozenges — gluconate or acetate — at >75 mg elemental zinc/day reduce cold duration by roughly one day when started within 24 hours of symptom onset, with substantial heterogeneity and a meaningful taste-related dropout rate [4]. Mechanistically the effect appears local — free Zn²⁺ ions in the oropharynx interfere with rhinovirus replication and ICAM-1-mediated cell entry — not systemic, which is why the lozenge form, the dose, and the timing all matter and capsule forms of zinc do not produce the same effect.

Outside the cold context, gluconate is a competent, low-cost daily-repletion form. It absorbs better with food (gastric acid promotes ionization) and is mildly more likely to cause nausea on an empty stomach than bisglycinate. The cold-trial doses are not appropriate for daily long-term use — 75–100 mg/day elemental zinc for 5–7 days during an acute respiratory infection is one thing; the same dose held for months will reliably induce copper deficiency.

Cost-per-dose: $0.02–0.06 per 15 mg elemental serving. The cheapest evidence-backed option for repletion.

Zinc bisglycinate (glycinate)

Zinc bisglycinate is zinc chelated to two glycine molecules. The chelate is electrically neutral and stable across gastric pH, which is the pharmacokinetic argument for better intestinal absorption with less competition from phytates and other minerals. A 2007 small head-to-head study reported higher serum zinc AUC after a single dose of zinc bisglycinate compared to zinc gluconate in healthy adults [5]; a separate study in zinc-deficient children found higher repletion-rate and lower GI complaint frequency vs zinc sulfate [6]. The literature is thin but consistent in direction.

What bisglycinate is genuinely best for: people who report nausea, metallic taste, or stomach upset on other zinc forms; people taking 30+ mg elemental zinc daily over weeks (for acne, dermatitis, or post-deficiency repletion); and contexts where the supplement is taken with a meal that contains phytate-rich foods (whole grains, legumes), which can suppress absorption of less-stable zinc forms. The glycine moiety itself contributes a small additional amount of glycine but at supplement doses is not pharmacologically meaningful — do not buy bisglycinate as a glycine source.

Cost-per-dose: $0.06–0.18 per 15–30 mg elemental serving. The "premium daily" tier with the cleanest tolerability profile.

Zinc-carnosine (polaprezinc)

Zinc-carnosine (international nonproprietary name polaprezinc) is zinc complexed to L-carnosine in a 1:1 polymer. In Japan it is an approved prescription drug for gastric ulcer treatment, marketed under the brand name Promac and used clinically since 1994. Outside Japan it is sold as a supplement at 75–150 mg/day (delivering roughly 17–34 mg elemental zinc). The relevant evidence base is gastric, not systemic: polaprezinc accumulates in gastric mucosa, has antioxidant and anti-apoptotic effects on epithelial cells, and has held up across several Japanese RCTs and a smaller Western literature on NSAID-induced gastropathy, functional dyspepsia, and Helicobacter pylori eradication when added to triple therapy [7][8].

The H. pylori finding is the most striking. Polaprezinc added to standard PPI-based triple therapy has produced roughly 8–12 percentage-point improvements in eradication rates across several Japanese trials and meta-analyses, with the largest effect in clarithromycin-resistant strains [8]. Mechanistic work suggests both direct anti-H. pylori activity and improved gastric mucosal repair. This is not the same as recommending zinc-carnosine as a stand-alone H. pylori treatment — it is an adjunct to antibiotics, not a replacement.

Side effects are mild: constipation in some patients, occasional taste disturbance. The main caveat is long-term elemental zinc dose — 34 mg/day for several months will draw down copper stores in the same way other forms do, and most clinical protocols treat polaprezinc as a short-to-medium course (4–12 weeks), not indefinite supplementation.

Cost-per-dose: $0.40–1.20 per 75 mg polaprezinc serving in the US. The most expensive form here, justified for the specific gastric indication and not otherwise.

Head-to-head matrix

Which form should you pick — decision tree

Evidence quality call-out

Picolinate: Tier 3. One supportive small RCT from 1987, modest follow-on work; clinical endpoints are form-agnostic. Marketing exceeds evidence.

Gluconate (lozenge form, cold duration): Tier 2. Consistent direction-of-effect across >20 trials; heterogeneity is real; effect size is meaningful (~1 day) when protocol is followed [3][4].

Bisglycinate: Tier 2 for tolerance/absorption advantage; Tier 1 for general zinc-repletion endpoints (which apply to all forms at adequate dose).

Carnosine (polaprezinc): Tier 1 for gastric mucosal endpoints in Japanese clinical use. Most of the literature is Japanese-language journals; English-language meta-analyses are sparser but converge on the same direction [7][8].

Funder mix: cold-lozenge literature is heavily public/academic with some industry contributions; polaprezinc literature is dominated by the Japanese pharmaceutical sponsor (Zeria Pharmaceutical) with independent academic replications; picolinate's seminal study was investigator-initiated and small. We weight effect sizes accordingly.

Common misconceptions

"Picolinate is the best-absorbed form." The original 1987 study is real but small, has not been convincingly replicated, and modern reviews place picolinate within the broad range of organic zinc chelates — not above bisglycinate, citrate, or gluconate at meaningful margins [2]. If a brand's pitch depends on this claim, the claim is older than the brand's chemist.

"Any zinc form shortens colds." The cold-duration effect is specific to ionic zinc lozenges (gluconate or acetate) at >75 mg/day elemental zinc started within 24 hours. Swallowing a 15 mg zinc picolinate capsule once a day does not produce the local oropharyngeal Zn²⁺ exposure the mechanism requires [3][4].

"Zinc and iron compete, so I should never take them together." Acute high-dose iron blunts zinc absorption when taken in the same dose; routine dietary iron and modest-dose supplemental zinc with food don't appreciably interfere. Where this matters: a 60 mg ferrous sulfate plus 50 mg elemental zinc megadose taken at the same time will reduce zinc absorption — separate by 2 hours.

"Zinc-carnosine is just glorified zinc." The clinical evidence for polaprezinc on gastric mucosa is form-specific — it relies on the carnosine moiety's local antioxidant activity at the gastric epithelium, not simply on the zinc cation. Equivalent elemental doses of zinc gluconate or picolinate have not replicated polaprezinc's effects on gastric endpoints [7].

"High-dose zinc supports immunity." Replenishing zinc when you're deficient supports normal immune function; loading additional zinc on top of an already-replete diet does not enhance it and over months can produce copper deficiency, neutropenia, and a peripheral myelopathy. The therapeutic window is narrower than the supplement industry implies [1].

Who should not take any of these

People taking tetracyclines, fluoroquinolones, or penicillamine should separate zinc dosing by at least 2 hours — zinc chelates these drugs and reduces their bioavailability. People with copper deficiency or Menkes disease, anyone on long-term high-dose zinc without copper supplementation, people taking immunosuppressants where altered zinc metabolism is a known interaction, and patients on chemotherapy or radiation should clear zinc supplementation with their oncologist. Pregnancy and lactation tolerate normal doses (8–13 mg/day) of any of these forms but the cold-lozenge doses (75–100 mg/day) are not recommended during pregnancy. People with hereditary haemochromatosis should not megadose zinc as a "treatment" for iron overload — the mechanism does not work and the side-effects are real.

What we'd actually buy

For the median person who wants a daily zinc supplement to back-fill dietary gaps, third-party-tested zinc bisglycinate at 15 mg elemental zinc/day with the largest meal of the day, indefinitely, with 1–2 mg copper added if intake will exceed 3 months. For active cold support, the cheapest gluconate or acetate lozenge from a verified-testing brand (look for USP, NSF, or Informed Sport markings), at the trial-validated protocol, used for the duration of the cold and then stopped. For functional dyspepsia or pre-eradication H. pylori support, a 75 mg polaprezinc tablet twice daily for 8 weeks, ideally under physician supervision.

None of these recommendations are sponsored. Verified-tested brand options are listed on each form's individual page (look for the "Verified brands" panel).